A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization

EMBO Journal

Volumn 22, Issue 8, 2003, Pages 1753-1761

  Wilczynska, Malgorzata ^a   Lobov, Sergei ^a   Ohlsson, Per Ingvar ^a   Ny, Tor ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

PAI 2; Polymerization; Redox; Serpin

Indexed keywords

DISULFIDE; MUTANT PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THIOL GROUP;

ARTICLE; BETA SHEET; CELL FRACTIONATION; CYTOSOL; DISULFIDE BOND; GENE INSERTION; HYDROPHOBICITY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN POLYMERIZATION; PROTEIN STABILITY;

CYSTEINE; DISULFIDES; HUMANS; MODELS, MOLECULAR; OXIDATION-REDUCTION; PEPTIDES; PLASMINOGEN ACTIVATOR INHIBITOR 2; POLYMERS; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0037446935     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg178     Document Type: Article

References (57)

1. Bachmann, F. (1995) The enigma PAI-2. Gene expression, evolutionary and functional aspects. Thromb. Haemost., 74, 172-179.
2. Baumann, U., Huber, R., Bode, W., Grosse, D., Lesjak, M. and Laurell, C.B. (1991) Crystal structure of cleaved human α1-antichymotrypsin at 2.7 Å resolution and its comparison with other serpins. J. Mol. Biol., 218, 595-606.
3. Belin, D., Wohlwend, A., Schleuning, W.D., Kruithof, E.K. and Vassalli, J.D. (1989) Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activator inhibitor 2. EMBO J., 8, 3287-3294.
4. Björk, I., Ylinenjarvi, K., Olson, S.T. and Bock, P.E. (1992) Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor. J. Biol. Chem., 267, 1976-1982.
5. Björquist, P., Ehnebom, J., Inghardt, T., Hansson, L., Lindberg, M., Linschoten, M., Stroemqvist, M. and Deinum, J. (1998) Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis. Biochemistry, 37, 1227-1234.
6. Busby, T.F., Atha, D.H. and Ingham, K.C. (1981) Thermal denaturation of antithrombin III. Stabilization by heparin and lyotropic anions. J. Biol. Chem., 256, 12140-12147.
7. Chang, W.S., Wardell, M.R., Lomas, D.A. and Carrell, R.W. (1996) Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem. J., 314, 647-653.
8. Chang, W.S., Whisstock, J., Hopkins, P.C., Lesk, A.M., Carrell, R.W. and Wardell, M.R. (1997) Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins. Protein Sci., 6, 89-98.
9. Dafforn, T.R., Mahadeva, R., Elliott, P.R., Sivasothy, P. and Lomas, D.A. (1999) A kinetic mechanism for the polymerization of α1-antitrypsin. J. Biol. Chem., 274, 9548-9555.
10. Desai, U.R., Johns, J.L., Lahaye, L. and Wright, H.T. (2002) Probing reactive center loop insertion in serpins: a simple method for ovalbumin. Anal. Biochem., 302, 81-87.
11. Dickinson, J.L., Bates, E.J., Ferrante, A. and Antalis, T.M. (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem., 270, 27894-27904.
12. Egelund, R., Einholm, A.P., Pedersen, K.E., Nielsen, R.W., Christensen, A., Deinum, J. and Andreasen, P.A. (2001) A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization. J. Biol. Chem., 276, 13077-13086.
13. Elliott, P.R., Pei, X.Y., Daffom, T.R. and Lomas, D.A. (2000) Topography of a 2.0 Å structure of α1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci., 9, 1274-1281.
14. Fa, M., Bergstrom, F., Hagglof, P., Wilczynska, M., Johansson, L.B. and Ny, T. (2000) The structure of a serpin-protease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites. Structure Fold Des., 8, 397-405.
15. Fitton, H.L., Pike, R.N., Carrell, R.W. and Chang, W.S. (1997) Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. Biol. Chem., 378, 1059-1063.
16. Genton, C., Kruithof, E.K. and Schleuning, W.D. (1987) Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J. Cell Biol., 104, 705-712.
17. Harrop, S.J. et al. (1999) The crystal structure of plasminogen activator inhibitor 2 at 2.0 Å resolution: implications for serpin function. Structure Fold Des., 7, 43-54.
18. Huber, R. and Carrell, R.W. (1989) Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins. Biochemistry, 28, 8951-8966.
19. Huntington, J.A., Read, R.J. and Carrell, R.W. (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature, 407, 923-926.
20. Jankova, L., Harrop S.J., Saunders, D.N., Andrews, J.L., Bertram, K.C., Gould, A.R., Baker, M.S. and Curmi, P.M. (2001) Crystal structure of the complex of plasmmogen activator inhibitor 2 with a peptide mimicking the reactive center loop. J. Biol. Chem., 276, 43374-43382.
21. Jensen, P.H. Lorand, L., Ebbesen, P. and Gliemann, J. (1993) Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur. J. J. Biochem. 214, 141-146.
22. Jensen, P.H., Jensen, T.G., Laug, W.E., Hager, H., Gliemann, J. and Pepinsky, B. (1996) The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain. J. Biol. Chem., 271, 26892-26899.
23. Kruithof, E.K., Baker, M.S. and Bunn, C.L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood, 86, 4007-4024.
24. Kumar, S. and Baglioni, C. (1991) Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem., 266, 20960-20964.
25. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
26. Lawrence, D.A., Ginsburg, D., Berkenpas, M.B., Verhamme, I.M., Kvassman, J.O. and Shore, J.D. (1995) Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem., 270,25309-25312.
27. Li, J., Wang, Z., Canagarajah, B., Jiang, H., Kanost, M. and Goldsmith, E.J. (1999) The structure of active serpin 1K from Manduca sexta. Structure Fold Des., 7, 103-109.
28. Li, P.P., Nakanishi, A., Clark, S.W. and Kasamatsu, H. (2002) Formation of transitory intrachain and interchain disulfide bonds accompanies the folding and oligomerization of simian virus 40 Vp1 in the cytoplasm. Proc. Natl Acad. Sci. USA, 99, 1353-1358.
29. Loebermann, H., Tokuoka, R., Deisenhofer, J. and Huber, R. (1984) Human α1-proteinase inhibitor. J. Mol. Biol., 177, 531-556.
30. Lomas, D.A., Evans, D.I., Finch, J.T. and Carrell, R.W. (1992) The mechanism of Z α1-antitrypsin accumulation in the liver. Nature, 357, 605-607.
31. Lomas, D.A., Evans, D.L., Stone, S.R., Chang, W.S. and Carrell, R.W. (1993) Effect of the Z mutation on the physical and inhibitory properties of α1-antitrypsin. Biochemistry, 32, 500-508.
32. Longas, M.O., Ferguson, W.S. and Finlay, T.H. (1980) A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation. J. Biol. Chem., 255, 3436-3441.
33. Mast, A.E., Enghild, J.J. and Salvesen, G. (1992) Conformation of the reactive site loop of α1-proteinase inhibitor probed by limited proteolysis. Biochemistry, 31, 2720-2728.
34. Mikus, P. and Ny, T. (1996) Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J. Biol. Chem., 271, 10048-10053.
35. Mikus, P., Urano, T., Liljestrom, P. and Ny, T. (1993) Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising serpin. Biochemical characterisation of the recombinant intracellular and extracellular forms. Eur. J. Biochem., 218, 1071-1082.
36. Ny, T., Hansson, L., Lawrence, D., Leonardsson, G. and Astedt, B. (1989) Plasminogen activator inhibitor type 2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted. Fibrinolysis, 3, 189-196.
37. Patston, P.A., Hauert, J., Michaud, M. and Schapira, M. (1995) Formation and properties of C1-inhibitor polymers. FEBS Lett., 368, 401-404.
38. Risse, B.C., Brown,H., Lavker, R.M., Pearson, J.M., Baker, M.S., Ginsburg,D. and Jensen,P.J. (1998) Differentiating cells of murine stratified squamous epithelia constitutively express plasminogen activator inhibitor type 2 (PAI-2). Histochem. Cell Biol., 110, 559-569.
39. Silverman, G.A. et al. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions and a revised nomenclature. J. Biol. Chem., 276, 33293-33296.
40. Simonovic, I. and Patston, P.A. (2000) The native metastable fold of C1-inhibitor is stabilized by disulfide bonds. Biochim. Biophys. Acta, 1481, 97-102.
41. Skinner, R., Chang, W.S., Jin, L., Pei, X., Hunfington, A., Abrahams, J.P., Carrell, R.W. and Lomas, D.A. (1998) Implications for function and therapy of a 2.9 Å structure of binary-complexed antithrombin. J. Mol. Biol., 283, 9-14.
42. Stein, P.E. and Carrell, R.W. (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat. Struct. Biol., 2, 96-113.
43. Stein, P. and Chothia, C. (1991) Serpin tertiary structure transformation. J. Mol. Biol., 221, 615-621.
44. Stein, P.E., Leslie, A.G., Finch, J.T., Turnell, W.G., McLaughlin, P.J. and Carrell, R.W. (1990) Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature, 347, 99-102.
45. Stratikos, E. and Gettins, P.G. (1997) Major proteinase movement upon stable serpin-proteinase complex formation. Proc. Natl Acad. Sci. USA, 94, 453-458.
46. Sun, X.J. and Chang, J.Y. (1989) Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. An efficient method for structural analysis of partially reduced proteins. J. Biol. Chem., 264, 11288-11293.
47. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
48. von Heijne, G., Liljestrom, P., Mikus, P., Andersson, H. and Ny, T. (1991) The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity. J. Biol. Chem., 266, 15240-15243.
49. 1-antitrypsin. J. Mol. Biol., 296, 685-699.
50. White, C.L., Senkevich, T.G. and Moss, B. (2002) Vaccinia virus G4L glutaredoxin is an essential intermediate of a cytoplasmic disulfide bond pathway required for virion assembly. J. Virol., 76, 467-472.
51. Wilczynska, M., Fa, M., Ohlsson, P.I. and Ny, T. (1995) The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex. J. Biol. Chem., 270, 29652-29655.
52. Wilczynska, M., Fa, M., Karolin, J., Ohlsson, P.I., Johansson, L.B. and Ny, T. (1997) Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol., 4, 354-357.
53. Wilczynska, M., Lobov, S. and Ny, T. (2003) The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations. FEBS Lett., 537, 11-16.
54. Williams, D.L., Risse, B., Kim, S., Saunders, D., Orlin, S., Baker, M.S., Jensen, P.J. and Lavker, R.M. (1999) Plasminogen activator inhibitor type 2 in human corneal epithelium. Invest. Ophthalmol. Vis. Sci., 40, 1669-1675.
55. Wohlwend, A., Belin, D. and Vassalli, J.D. (1987) Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion. J. Immunol., 139, 1278-1284.
56. Ye, R.D., Wun, T.C. and Sadler, J.E. (1988) Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J. Biol. Chem., 263, 4869-4875.
57. Ye, R.D., Ahern, S.M., Le-Beau, M.M., Lebo, R.V. and Sadler, J.E. (1989) Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J. Biol. Chem., 264, 5495-5502.